DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 60 filers reported holding DOVA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $9,241,000 | +303.0% | 330,621 | +103.3% | 0.13% | +271.4% |
Q2 2019 | $2,293,000 | +57.3% | 162,598 | -0.8% | 0.04% | +52.2% |
Q1 2019 | $1,458,000 | +7.8% | 163,989 | -8.1% | 0.02% | -14.8% |
Q4 2018 | $1,353,000 | -68.0% | 178,536 | -11.5% | 0.03% | -60.3% |
Q3 2018 | $4,228,000 | -2.3% | 201,625 | +39.3% | 0.07% | -4.2% |
Q2 2018 | $4,329,000 | +11.7% | 144,699 | +1.3% | 0.07% | +9.2% |
Q1 2018 | $3,875,000 | – | 142,895 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 3,125,851 | $23,693,000 | 0.90% |
Broadfin Capital, LLC | 351,800 | $2,667,000 | 0.35% |
Birchview Capital, LP | 40,000 | $303,000 | 0.29% |
SPHERA FUNDS MANAGEMENT LTD. | 185,000 | $1,402,000 | 0.16% |
Fosun International Ltd | 261,780 | $1,984,000 | 0.12% |
Spark Investment Management LLC | 61,100 | $463,000 | 0.03% |
Candriam S.C.A. | 233,200 | $1,768,000 | 0.03% |
GW&K Investment Management, LLC | 178,536 | $1,353,000 | 0.03% |
Tower Research Capital LLC (TRC) | 20,613 | $156,000 | 0.01% |
Point72 Hong Kong Ltd | 1,456 | $11,000 | 0.01% |